Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (281-290 of 364) with videos related to

Pageof 37
Sort By:
EMBO Molecular Medicine|April 24, 2020
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stressJuliette Humeau, Allan Sauvat, Giulia Cerrato, et al.
Blood|November 3, 2016
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patientsJitka Fucikova, Iva Truxova, Michal Hensler, et al.
Scientific Reports|November 4, 2017
Identification of pharmacological agents that induce HMGB1 releasePeng Liu, Liwei Zhao, Friedemann Loos, et al.
Cell Death and Differentiation|October 24, 2018
Recruitment of LC3 to damaged Golgi apparatusLígia C Gomes-da-Silva, Ana Joaquina Jimenez, Allan Sauvat, et al.
Microbial Cell (Graz, Austria)|May 23, 2019
Targeting GATA transcription factors - a novel strategy for anti-aging interventions?Andreas Zimmermann, Katharina Kainz, Sebastian J Hofer, et al.
Autophagy|June 29, 2019
4,4'Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effectsAndreas Zimmermann, Katharina Kainz, Sebastian J Hofer, et al.
Cell Death & Disease|November 27, 2020
Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapyQi Wu, Ai-Ling Tian, Sylvère Durand, et al.
Oncoimmunology|December 15, 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon, Kristina Iribarren, Florent Petitprez, et al.
Cell Death & Disease|October 22, 2021
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtypeJiayin Deng, Ai-Ling Tian, Hui Pan, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Local anesthetics elicit immune-dependent anticancer effectsLucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Pageof 37

Showing results (281-290 of 364) with videos related to

Sort By:
Pageof 37
EMBO Molecular Medicine|April 24, 2020
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stressJuliette Humeau, Allan Sauvat, Giulia Cerrato, et al.
Blood|November 3, 2016
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patientsJitka Fucikova, Iva Truxova, Michal Hensler, et al.
Scientific Reports|November 4, 2017
Identification of pharmacological agents that induce HMGB1 releasePeng Liu, Liwei Zhao, Friedemann Loos, et al.
Cell Death and Differentiation|October 24, 2018
Recruitment of LC3 to damaged Golgi apparatusLígia C Gomes-da-Silva, Ana Joaquina Jimenez, Allan Sauvat, et al.
Microbial Cell (Graz, Austria)|May 23, 2019
Targeting GATA transcription factors - a novel strategy for anti-aging interventions?Andreas Zimmermann, Katharina Kainz, Sebastian J Hofer, et al.
Autophagy|June 29, 2019
4,4'Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effectsAndreas Zimmermann, Katharina Kainz, Sebastian J Hofer, et al.
Cell Death & Disease|November 27, 2020
Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapyQi Wu, Ai-Ling Tian, Sylvère Durand, et al.
Oncoimmunology|December 15, 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon, Kristina Iribarren, Florent Petitprez, et al.
Cell Death & Disease|October 22, 2021
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtypeJiayin Deng, Ai-Ling Tian, Hui Pan, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Local anesthetics elicit immune-dependent anticancer effectsLucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Pageof 37